Delivery Order SPE2DR25D3504-SPE2DR26F7BC3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,174.81 for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price contract, awarded on July 24, 2025, with completion scheduled for July 25, 2025, carries no set-aside designation and represents a competitively awarded procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, with a ceiling value of $20,404.44. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60 grams) valued at $1,493.37 with an ultimate completion date of October 30, 2025. This is a firm fixed price, non-set-aside contract executed on October 29, 2025, with performance based in Conshohocken, Pennsylvania, the company's corporate headquarters location. The award represents a single delivery order under AmerisourceBergen's larger federal contracting relationships supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,650.79 on September 15, 2025, for OPZELURA 1.5% Cream in 60-gram quantities, with final delivery scheduled by September 16, 2025. This non-competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $17,293.59, is for the delivery of OPZELURA 1.5% Cream in 60 gram packaging. The order is a firm fixed-price contract with a completion date of July 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram unit on September 4, 2025, with a ceiling value of $2,171.95. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $8,242.10 to AmerisourceBergen Drug Corp for OPZELURA 1.5% cream (60GM) on October 29, 2025, with an ultimate completion date of October 30, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed through the company's existing indefinite delivery contract with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DR25D3504Indefinite Delivery Contract
- SPE2DR25D3504-SPE2DR26F7BC3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,046.93 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities on November 18, 2025, with completion scheduled for November 19, 2025. This firm fixed-price contract represents a non-competitive set-aside award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order falls under AmerisourceBergen's comprehensive $999.99 billion IDC with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and functions as a global pharmaceutical support vehicle for military healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates extensive experience supplying brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to support Defense Health Agency and U.S. Coast Guard healthcare operations. The company's consistent receipt of competitively awarded contracts reflects its established capability to meet federal medical supply requirements at scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 11/18/25 |